U.S. Food, 2018-05-22: FDA press announcement dated 22 May 2018 warning that OTC benzocaine teething products pose a serious risk to infants and children and asking manufacturers to stop selling them for children under 2.
The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products containing benzocaine pose a serious risk to infants and children.
U.S. Food, 2018-05-22: FDA press announcement dated 22 May 2018 warning that OTC benzocaine teething products pose a serious risk to infants and children and asking manufacturers to stop selling them for children under 2. C2. The page states 'For Immediate Release: May 22, 2018' – one day before the Drug Safety Communication it announces (dated 05-23-2018), so the press item is dated 2018-05-22 and the companion communication 2018-05-23 (MTI-06). Names the OTC brands involved (Anbesol, Baby Orajel, Cepacol, Chloraseptic, Hurricaine, Orabase, Orajel, Topex, store brands and generics) and quotes FDA Commissioner Scott Gottlieb, M.D. Quote verified against the Internet Archive capture; the live URL returns 404 on the access date. Study type: regulatory record.
